International Journal of Antimicrobial Agents
One of ISAC’s principal activities is production of the International Journal of Antimicrobial Agents (IJAA) in collaboration with the publisher Elsevier.
The journal provides comprehensive and up-to-date peer reviewed reference information on the physical, pharmacological, in vitro and clinical properties of individual antimicrobial agents. In addition, it signals new trends and developments in the field through highly authoritative review articles on antimicrobial agents, immunomodulators and immunotherapy. Special attention is given to articles providing insight into the problems of antimicrobial resistance, local as well as worldwide, both in the hospital and in the community. Papers on the underlying mechanisms and on immunomodulating agents are also welcome. Both solicited reviews by top experts in the mentioned fields and high-quality original research papers are published.
The journal Editor in Chief is Prof. Jian Li, Monash University who took over from Prof. Jean-Marc Rolain as of 1 January 2023.
Prof. Rolain took over from Prof. Alasdair Geddes’ after his retirement in 2015. Under Prof. Geddes’ and Prof. Rolain's expert stewardship, the Journal has gone from strength to strength over the last 15 years.
The 2024 impact factor currently stands at 4.6 (© Clarivate Analytics). IJAA is now ranked in the following positions in the Journal Citation Reports:
- Infectious Diseases 17 / 137 journals
- Microbiology: 34 / 163 journals.
- Pharmacology & Pharmacy 58 / 353 journal
To submit a paper to IJAA
Reviews and original research articles are welcome. Special attention is given to those providing insight into the problems of antimicrobial resistance, local as well as worldwide, both in the hospital and in the community. Papers on the underlying mechanisms and on immunomodulating agents are also accepted.
